Moving Continuous Processing from an Emerging Technology to a Commercialized Enabler
March 7-9 |Boston
Welcome to the 7th Annual Commercializing Continuous Processing Summit
Marry Technical Insight & Strategic Know-How to Access the Capital Gains, On-Shored Sustainable Supply Chains, Flexible & Modular Platforms of Small & Large Molecule Continuous Manufacturing
As more companies are gearing up towards commercial filing, CCP 2023 is set to be the largest and most comprehensive summit to date. Spanning 3 days and 3 tracks of content across small molecules, biologics and regulatory CMC, join the only industry driven event that provides a snapshot of the latest developments, innovations, and commercial applications of continuous processing across all modality applications.
The ’double-edged sword’ program combining both technical case studies and strategical talks, will enable you to truly unearth CM’s place in the evolving regulatory landscape, ensure quality control strategy is right first time, and explore the industry shift towards modularization.
Hosting leading companies and minds in the space, explore the end-to-end integration of continuous manufacturing in healthcare, alongside 200+ senior attendees from process development and engineering, manufacturing, CMC, regulatory affairs, QA/QC, MS&T.
World-Class Speaker Faculty Includes:
Engin Ayturk
Executive Director, CMC Process Engineering & Bio-Conjugation Development,
Mersana Therapeutics
Snapshot of Attending Organizations from Last Year:
Program Partners
Innovation Partners
Exhibition Partner
Other Events in the Series
